Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma

Oncology Reports

Volumn 20, Issue 6, 2008, Pages 1441-1447

  Zhong, Lai Ping ^a   Yang, Xiao ^a   Zhang, Lei ^a   Wei, Kui Jie ^a   Pan, Hong Ya ^a   Zhou, Xiao Jian ^a   Li, Jiang ^a   Chen, Wan Tao ^a   Zhang, Zhi Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

In vitro; In vivo; Insulin like growth factor binding protein 3; Oral squamous cell carcinoma

Indexed keywords

MESSENGER RNA; MOLECULAR MARKER; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER SIZE; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; ORAL SURGERY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; BIOLOGICAL MODEL; EPITHELIUM; METABOLISM; METASTASIS; METHODOLOGY; MOUTH TUMOR; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; MOUTH NEOPLASMS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 59249088929     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000164     Document Type: Article

References (44)

1. Kademani D: Oral cancer. Mayo Clin Proc 82: 878-887, 2007.
2. Petersen PE: The World Oral Health Report 2003: Continuous improvement of oral health in the 21st century-the approach of WHO Global Oral Programme. Community Dent Oral Epidemiol 31 (Suppl 1): 3-23, 2003.
3. Neville BW and Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195-215, 2002.
4. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
5. Sdek P, Zhang ZY, Cao J, Pan HY, Chen WT and Zheng JW: Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Int J Oral Maxillofac Surg 35: 653-657, 2006.
6. Zhong LP, Pan HY, Zhou XJ, et al: Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line. Arch Oral Biol 53: 443-452, 2008.
7. Binoux, M: Insulin-like growth factor binding proteins (IGFBPs): physiological and clinical implications. J Pediatr Endocrinol Metab 3: 285-288, 1996.
8. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649, 1995.
9. Rajah R, Valentinis B and Cohen P: Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272: 12181-12188, 1997.
10. Chang YS, Kong G, Sun S, et al: Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer. Clin Cancer Res 8: 3796-3802, 2002.
11. Unsal E, Köksal D, Yurdakul AS, Atikcan S and Cinaz P: Analysis of insulin like growth factor 1 and insulin-like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Respir Med 99: 559-565, 2005.
12. Yu H, Spitz MR, Mistry J, Gu J, Hong WK and Wu X: Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. Natl Cancer Inst 91: 151-156, 1999.
13. Aishima S, Basaki Y, Oda Y, et al: High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma. Cancer Sci 97: 1182-1190, 2006.
14. Hanafusa T, Yumoto Y, Nouso K, et al: Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett 176: 149-158, 2002.
15. Walker G, MacLeod K, Williams AR, Cameron DA, Smyth JF and Langdon SP: Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancer. Clin Cancer Res 13: 1438-1444, 2007.
16. Hampel OZ, Kattan MW, Yang G, et al: Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study. J Urol 159: 2220-2225, 1998.
17. Shariat SF, Lamb DJ, Kattan MW, et al: Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. J Clin Oncol 20: 833-841, 2002.
18. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS and Plymate SR: Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J Clin Endocrinol Metab 81: 411-420, 1996.
19. Chuang ST, Patton KT, Schafernak KT, et al: Overexpression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma. J Urol 179: 445-449, 2008.
20. Takahashi M, Papavero V, Yuhas J, et al: Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol 26: 923-931, 2005.
21. Hintz RL, Bock S, Thorsson AV, Bovens J, Powell DR, Jakse G and Petrides PE: Expression of the insulin like growth factor-binding protein 3 (IGFBP-3) gene is increased in human renal carcinomas. J Urol 146: 1160-1163, 1991.
22. Takaoka M, Harada H, Andl CD, et al: Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3. Cancer Res 64: 7711-7723, 2004.
23. Vadgama JV, Wu Y, Datta G, Khan H and Chillar R: Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 57: 330-340, 1999.
24. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM and Diamandis EP: Insulin-like growth factor-binding protein-3 and breast cancer survival. Int J Cancer 79: 624-628, 1998.
25. Vestey SB, Perks CM, Sen C, Calder CJ, Holly JM and Winters ZE: Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome. Breast Cancer Res 7: R119-R129, 2005.
26. Jenkins PJ, Khalaf S, Ogunkolade W, et al: Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis. Endocr Relat Cancer 12: 891-901, 2005.
27. Berger AJ, Baege A, Guillemette T, et al: Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. Am J Pathol 161: 603-610, 2002.
28. Papadimitrakopoulou VA, Brown EN, Liu DD, El-Naggar AK, Jack Lee J, Hong WK and Lee HY: The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis. Cancer Lett 239: 136-143, 2006.
29. Wu X, Zhao H, Do KA, Johnson MM, Dong Q, Hong WK and Spitz MR: Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res 10: 3988-3995, 2004.
30. Zhong LP, Chen WT, Zhang CP and Zhang ZY: Increased CK19 expression correlated with pathological differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104: 377-384, 2007.
31. Zhong LP, Zhang CP, Li J, Chen WT and Zhang ZY: Increase of Cyfra 21-1 concentration in saliva from oral squamous cell carcinoma patients. Arch Oral Biol 52: 1079-1087, 2007.
32. Sobin LH and Wittekind CH (ed): International Union Against Cancer (UICC). TNM classification of malignant tumours, 6th edition. Wiley-Liss, New York, pp22-26, 2002.
33. Barnes L, Eveson JW, Reichart P and Sidransky D (ed): World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon, pp168-175, 2005.
34. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 25: 402-408, 2001.
35. Zhong LP, Li J, Zhang CP, Zhu HG, Sun J and Zhang ZY: Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol 52: 740-747, 2007.
36. Lenaerts K, Bouwman FG, Lamers WH, Renes J and Mariman EC: Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics 8: 91, 2007.
37. Firth SM and Baxter RC: Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854, 2002.
38. Grimberg A and Cohen P: Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183: 1-9, 2000.
39. Grill CJ and Cohick WS: Insulin-like growth factor binding protein-3 mediates IGF-1 action in a bovine mammary epithelial cell line independent of an IGF interaction. J Cell Physiol 183: 273-283, 2000.
40. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CTJ and Fontana JA: Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-1 (IGF-1)-mediated DNA synthesis and IGF-1 binding in a human breast carcinoma cell line. J Cell Physiol 158: 69-78, 1994.
41. Conover CA: Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130: 191-199, 1992.
42. Clemmons DR: Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8: 45-62, 1997.
43. Grimberg A: Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther 2: 630-635, 2003.
44. Kelley KM, Oh Y, Gargosky SE, et al: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28: 619-637, 1996.